Back to search
CASPR2-Antibody
Clinical trial pipeline · Data from ClinicalTrials.gov
See which CASPR2-Antibody trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which CASPR2-Antibody trials you may qualify forAutoimmune encephalitides are severe neurological disorders requiring urgent treatment, even though there is no standard guideline by lack of empirical evidence…
The Swiss-Ped-IBrainD is a national patient registry that collects information on diagnosis, symptoms, treatment, and follow-up of pediatric patients with an in…
Anti-CASPR2 limbic encephalitis (CASPR2-LE) is a rare neurological disorder primarily affecting males over the age of 50. It is mediated by an autoimmune antibo…
Auto-immune encephalitides involve auto-antibodies targeting the central nervous system, and particularly the synapse and its structure, such as protein CASPR2.…